皮肤黑色素瘤中铁死亡相关基因特征及预后风险模型的分析与评估

Analysis and assessment of ferroptosis-related gene signatures and prognostic risk models in skin cutaneous melanoma.

作者信息

Ma Jianchao, Cai Yang, Lu Youqi, Fang Xu

机构信息

Department of Orthopedics, Minzu Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Department of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

出版信息

Transl Cancer Res. 2025 Mar 30;14(3):1857-1873. doi: 10.21037/tcr-24-1506. Epub 2025 Mar 19.

Abstract

BACKGROUND

The occurrence and development of skin cutaneous melanoma (SKCM) are significantly influenced by ferroptosis, a sort of regulated cell death characterized by iron deposition and lipid peroxidation. Although positive strides have been achieved in the present management of SKCM, it is still unknown exactly how ferroptosis occurs in this condition. We aimed to determine the role of prognostically relevant ferroptosis-related genes (PR-FRGs) in SKCM development and prognosis.

METHODS

The training group was created using combined transcriptomic RNA data acquired from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases. The dataset GSE19234 was acquired from the Gene Expression Omnibus (GEO) database as a validation group. Differentially expressed ferroptosis-related genes (DE-FRGs) were obtained from the training group, of which 103 showed up-regulation and 77 showed down-regulation. Then, 12 PR-FRGs were identified by the protein-protein interaction (PPI) network and Cox regression analysis, and prognostic risk models and nomograms were constructed. The risk model was validated using a validation group, and the prognostic value of the risk model was analyzed. Finally, immunohistochemical data were obtained from the Human Protein Atlas (HPA) website to validate the PR-FRGs.

RESULTS

Twelve PR-FRGs were identified. A prognostic risk model was built using PR-FRGs, and patients in the training and validation groups were classified as high or low risk based on the risk model. The outcomes demonstrated that the prognosis was better for the low-risk group. Prognostic value analysis showed that the prognostic risk model could accurately predict the patients' overall survival (OS), was superior to clinical traits such as age, gender, and tumor stage in predicting ability, and could be used as an independent predictor. Meanwhile, the nomogram constructed based on PR-FRGs can effectively predict the prognosis of SKCM patients. Finally, PR-FRGs were validated in the HPA database.

CONCLUSIONS

Ferroptosis affects the prognosis of SKCM patients. Prognostic risk model and nomogram constructed based on 12 PR-FRGs demonstrated significant advantages in predicting the prognosis of SKCM patients. This will help in the identification and prognostic prediction of SKCM and in the discovery of new individualized treatment modalities.

摘要

背景

皮肤黑色素瘤(SKCM)的发生和发展受到铁死亡的显著影响,铁死亡是一种以铁沉积和脂质过氧化为特征的程序性细胞死亡。尽管目前SKCM的治疗已取得积极进展,但铁死亡在这种疾病中的确切发生机制仍不清楚。我们旨在确定与预后相关的铁死亡相关基因(PR-FRGs)在SKCM发生发展及预后中的作用。

方法

利用从癌症基因组图谱(TCGA)和基因型-组织表达(GTEx)数据库获取的转录组RNA数据组合创建训练组。从基因表达综合数据库(GEO)获取数据集GSE19234作为验证组。从训练组中获得差异表达的铁死亡相关基因(DE-FRGs),其中103个呈上调,77个呈下调。然后,通过蛋白质-蛋白质相互作用(PPI)网络和Cox回归分析鉴定出12个PR-FRGs,并构建预后风险模型和列线图。使用验证组对风险模型进行验证,并分析风险模型的预后价值。最后,从人类蛋白质图谱(HPA)网站获取免疫组化数据以验证PR-FRGs。

结果

鉴定出12个PR-FRGs。使用PR-FRGs构建了预后风险模型,并根据该风险模型将训练组和验证组的患者分为高风险或低风险。结果表明,低风险组的预后较好。预后价值分析表明,预后风险模型能够准确预测患者的总生存期(OS),在预测能力上优于年龄、性别和肿瘤分期等临床特征,并且可以作为独立预测因子。同时,基于PR-FRGs构建的列线图能够有效预测SKCM患者的预后。最后,在HPA数据库中验证了PR-FRGs。

结论

铁死亡影响SKCM患者的预后。基于12个PR-FRGs构建的预后风险模型和列线图在预测SKCM患者预后方面显示出显著优势。这将有助于SKCM的识别和预后预测,并有助于发现新的个体化治疗模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c07/11985187/d05a870469a8/tcr-14-03-1857-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索